4.4 Review

Maternal metabolic factors and the association with gestational diabetes: A systematic review and meta-analysis

Journal

DIABETES-METABOLISM RESEARCH AND REVIEWS
Volume 38, Issue 5, Pages -

Publisher

WILEY
DOI: 10.1002/dmrr.3532

Keywords

body mass index; gestational diabetes; glucose; lipids; meta-analysis; metabolic syndrome; pregnancy

Funding

  1. Commonwealth of Australia
  2. Centre of Research Excellence in PCOS
  3. National Health and Medical Research Council [GNT 2009038]
  4. University of Adelaide, as part of the Wiley The University of Adelaide agreement via the Council of Australian University Librarians

Ask authors/readers for more resources

Gestational diabetes is associated with adverse outcomes for both the mother and child. Higher levels of individual lipids and a clustering of metabolic risk factors increase the risk of gestational diabetes. Early pregnancy assessment of glucose or the metabolic syndrome offers an opportunity for prevention and treatment of individual risk factors.
Gestational diabetes (GDM) is associated with several adverse outcomes for the mother and child. Higher levels of individual lipids are associated with risk of GDM and metabolic syndrome (MetS), a clustering of risk factors also increases risk for GDM. Metabolic factors can be modified by diet and lifestyle. This review comprehensively evaluates the association between MetS and its components, measured in early pregnancy, and risk for GDM. Databases (Cumulative Index to Nursing and Allied Health Literature, PubMed, Embase, and Cochrane Library) were searched from inception to 5 May 2021. Eligible studies included >= 1 metabolic factor (waist circumference, blood pressure, fasting plasma glucose (FPG), triglycerides, and high-density lipoprotein cholesterol), measured at I-2. Data were pooled by random-effects models and expressed as odds ratio and 95% confidence intervals (CIs). Of 7213 articles identified, 40 unique articles were included in meta-analysis. In analyses adjusting for maternal age and body mass index, GDM was increased with increasing FPG (odds ratios [OR] 1.92; 95% CI 1.39-2.64, k = 7 studies) or having MetS (OR 2.52; 1.65, 3.84, k = 3). Women with overweight (OR 2.17; 95% CI 1.89, 2.50, k = 12) or obesity (OR 4.34; 95% CI 2.79-6.74, k = 9) also were at increased risk for GDM. Early pregnancy assessment of glucose or the MetS, offers a potential opportunity to detect and treat individual risk factors as an approach towards GDM prevention; weight loss for pregnant women with overweight or obesity is not recommended. Systematic review registration: PROSPERO CRD42020199225.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available